DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV‐1 infection of macrophages

• Petra Mlcochova ^[3] ; Sarah J Caswell ^[1] ; Ian A Taylor ^[1] ; Greg J Towers ^[3] ; Ravindra K Gupta ^[2]
  1. [1] Francis Crick Institute

     Francis Crick Institute

     Reino Unido

     
  2. [2] Africa Health Research Institute

     Africa Health Research Institute

     Ethekwini, Sudáfrica

     
  3. [3] 1 Division of Infection and Immunity UCL London UK

  Mostrar afiliaciones +
• Localización: EMBO journal: European Molecular Biology Organization, ISSN 0261-4189, Vol. 37, Nº. 1, 2018, págs. 50-62
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • We report that DNA damage induced by topoisomerase inhibitors, including etoposide (ETO), results in a potent block to HIV‐1 infection in human monocyte‐derived macrophages (MDM). SAMHD1 suppresses viral reverse transcription (RT) through depletion of cellular dNTPs but is naturally switched off by phosphorylation in a subpopulation of MDM found in a G1‐like state. We report that SAMHD1 was activated by dephosphorylation following ETO treatment, along with loss of expression of MCM2 and CDK1, and reduction in dNTP levels. Suppression of infection occurred after completion of viral DNA synthesis, at the step of 2LTR circle and provirus formation. The ETO‐induced block was completely rescued by depletion of SAMHD1 in MDM. Concordantly, infection by HIV‐2 and SIVsm encoding the SAMHD1 antagonist Vpx was insensitive to ETO treatment. The mechanism of DNA damage‐induced blockade of HIV‐1 infection involved activation of p53, p21, decrease in CDK1 expression, and SAMHD1 dephosphorylation. Therefore, topoisomerase inhibitors regulate SAMHD1 and HIV permissivity at a post‐RT step, revealing a mechanism by which the HIV‐1 reservoir may be limited by chemotherapeutic drugs.